Tag: DREN
Cashew Identified as Increasingly Relevant Allergen Triggering Anaphylaxis in Children
Most frequent elicitors of tree nut-induced anaphylaxis in children were cashew, hazelnut, walnut
Pediatric Clavicular Fracture Rates Stable From 2014 to 2023
Adolescents aged 10 to 14 years were most injured age group; 79.3 percent of all clavicular fractures involving beds occurred in those younger than 5 years
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants
Pediatric Mycoplasma Pneumoniae Infection Incidence Increased in 2024
M. pneumoniae infections in 2024 not more severe than those in 2018 to 2023
FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis
Benlysta is the first and only approved autoinjector biologic for both systemic lupus erythematosus and lupus nephritis
Genetic Testing for Developmental Disabilities Low Among Children Enrolled in Medicaid
Proportion of children receiving genetic testing was highest for children with both autism spectrum disorder and intellectual disability
Two-Hour Observation Probably Safe for Most Children With Anaphylaxis
95.3 percent of children who present to ER with acute anaphylaxis would have been safely discharged two hours after first epinephrine dose
Biomarker Panel Improves Prediction of CKD Progression in Children
Urine/creatinine was the variable with the highest importance and ID'd highest risk group when combined with urine epidermal growth factor/creatinine
Relative Peripheral Refraction Predicts Myopia Progression in Children
Children with faster myopia progression have higher axial length, lower spherical equivalent, higher horizontal and vertical relative peripheral refraction
Deep Sleep, Daytime Control Key to Nocturnal Enuresis Management
Deep sleep and daytime urinary control more common in the treatment-responsive group
